Medicus Pharma Ltd. (MDCXW) Net Income towards Common Stockholders (2024 - 2026)
Medicus Pharma's (MDCXW) quarterly Net Income towards Common Stockholders came in at -$15.1 million in Q4 2025, down 326.05% YoY from $6.7 million in Q4 2024, and down 5763.14% on a QoQ basis from -$256984.0 in Q3 2025.
Medicus Pharma Ltd. (MDCXW) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Medicus Pharma (MDCXW) has 2 years of Net Income towards Common Stockholders data on file, last reported at -$15.1 million in Q4 2025.
- Quarterly Net Income towards Common Stockholders fell 326.05% year-over-year to -$15.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$27.1 million (down 144.34% YoY) and the FY2025 annual result came in at -$47.3 million, down 323.84% from the prior year.
- Net Income towards Common Stockholders retreated to -$15.1 million in Q4 2025, from -$256984.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$256984.0 in Q3 2025 to a low of -$15.1 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.68 Mn |
| Dec 31, 2025 | -15.07 Mn |
| Sep 30, 2025 | -256,984.00 |
| Jun 30, 2025 | -6.31 Mn |
| Mar 31, 2025 | -5.43 Mn |
| Dec 31, 2024 | -3.54 Mn |
| Sep 30, 2024 | -2.28 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | -1.71 Mn |